Testing effectiveness (Phase 2)Study completedNCT00245102
What this trial is testing
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
Who this might be right for
Adult AngiosarcomaAdult Epithelioid SarcomaAdult Leiomyosarcoma+12 more
National Cancer Institute (NCI) 147